Venediktov et al., 2023)
Not inhibitory to PTPalpha or LAR trilobolide-6-O-isobutyrate no inhibition at 0.026 mM tungstate ursolic acid uvaol - - vanadate VO3N3 - oxovanadium(IV) is coordinated with one nitrogen and two oxygen atoms from the Schiff base and two nitrogen atoms from the bidentate planar ligands, in a distorted octahedral geometry, VO3N3 wedelolide D 32% inhibition at 0.020 mM wedelolide H no inhibition at 0.023 mM wedelolide I no inhibition at 0.021 mM wedelolide J no inhibition at 0.021 mM ZINC39276654 used as scaffold for inhibitor design - Zn2+ [(4-[(4E)-2-(1H-benzotriazol-1-yl)-2-[4-(methoxycarbonyl)phenyl]-5-phenylpent-4-en-1-yl]phenyl)(difluoro)methyl]phosphonic acid - [(E)-2-nitroethenyl]benzene - [1,1'-biphenyl]-3-yl ethenesulfonate - [2-bromo-4-[(E)-(7,8-dimethyl-3-oxo[1,3]thiazolo[3,2-a]benzimidazol-2(3H)-ylidene)methyl]-6-ethoxyphenoxy]acetic acid irreversible inhibition [3-bromo-2-[(2,3-dibromo-4,5-dimethoxyphenyl)methyl]-4,5-dimethoxyphenyl]methanol 74.86% inhibition at 0.02 mg/ml [4-[(2E)-3-(5-bromo-4-hydroxy-2-methoxyphenyl)prop-2-enoyl]phenoxy]acetic acid - - [7-[4-[2-(1H-benzotriazol-1-yl)-2-[4-[difluoro(phosphono)methyl]phenyl]-3-phenylpropyl]phenyl]-2-(1-methoxy-3-methylbutyl)quinolin-8-yl]phosphonic acid - [[1-(4-chlorophenyl)-2-methyl-1H-indol-5-yl]oxy]acetic acid - [[4'-(2-butyl-1-benzofuran-3-yl)biphenyl-4-yl]oxy]acetic acid - 1,2-epoxy-3-(p-nitrophenoxy)propane C215D mutant, not wild type 2,3-diphosphoglycerate - activation 2-mercaptoethanol - activation 2-mercaptoethylamine - activation ADP - activation ATP dithiothreitol - activation DTT activates EDTA - activation glutathione - activation IGF-I - IGF-I stimulates p52shc phosphorylation, with a significantly greater increase in p52shc phosphorylation in the p66shc knockdown cells compared to control cells
How is AOD 9604 administered
Conclusion: Taken together, these data suggest that there is an acquisition of a SLP in hippocampal and cerebellar neurons in models of Type C HE, which may be attributable to HE-related hyperammonemia and contribute to the pathogenesis of Type C HE
